December 19, 2019 Our Picks for 2019's Top RA Studies Studies that explore the efficacy and safety of JAK inhibitors for rheumatoid arthritis are among those we selected as most noteworthy in 2019. Also, at the top of the list, a study that shows glucocorticoids, not necessarily biologics, raise the infection risk after joint replacement surgery. Learn more in this slideshow. Learn more   ADVERTISEMENT 2019's Top Treatment Advances in Lupus 2019 was a significant year for new developments in the treatment of systemic lupus. These include new treatment options for systemic lupus and updated treatment guidelines for established treatments. In this slideshow, we highlight a few of the achievements made throughout the year. Learn more   MORE FROM RHEUMATOLOGY NETWORK • 10 Notable Advances in Rheumatology from 2019 • Top 12 Rheumatology Books of 2019 • RA Quiz: Rheumatology Treatment Patterns Differ from Dermatology • 9 Facts About Step Therapy   RHEUMATOLOGY HEALTHCARE JOB OPPORTUNITIES Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.